Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1
Changes in Gut Microbiota and Postprandial GLP-1 Concentration Due to Sucralose Consumption
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
A NA clinical study on GLP-1 and Gut Microbiota, this trial is completed. The trial is conducted by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
May 2025 — Present [monthly]
Completed NA
-
Sep 2024 — May 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2024 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Nov 2023 — Apr 2024 [monthly]
Recruiting NA
First recorded
Jun 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
For direct contact, visit the study record on ClinicalTrials.gov .